| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 91.15B | 104.82B | 91.95B | 91.68B | 80.17B | 68.82B |
| Gross Profit | 16.72B | 21.45B | 15.36B | 11.65B | 9.05B | 8.46B |
| EBITDA | 9.77B | 12.39B | 9.29B | 5.77B | 4.37B | 3.52B |
| Net Income | 6.91B | 9.24B | 6.23B | 3.71B | 2.48B | 1.86B |
Balance Sheet | ||||||
| Total Assets | 70.56B | 100.70B | 80.86B | 84.01B | 78.94B | 72.08B |
| Cash, Cash Equivalents and Short-Term Investments | 13.12B | 26.39B | 18.53B | 18.77B | 17.67B | 19.51B |
| Total Debt | 4.70B | 8.29B | 3.99B | 3.55B | 3.36B | 3.88B |
| Total Liabilities | 29.48B | 49.83B | 38.83B | 45.25B | 43.56B | 37.72B |
| Stockholders Equity | 41.08B | 50.86B | 42.03B | 38.76B | 35.38B | 34.36B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.89B | -97.00M | 1.72B | -1.38B | 4.45B |
| Operating Cash Flow | 0.00 | 12.73B | 1.28B | 2.01B | -34.00M | 4.65B |
| Investing Cash Flow | 0.00 | -5.47B | 612.00M | -304.00M | -481.00M | 89.00M |
| Financing Cash Flow | 0.00 | 498.00M | -1.53B | -1.29B | -1.35B | -1.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥270.14B | 8.94 | 8.91% | 3.85% | 5.98% | 39.06% | |
78 Outperform | ¥104.31B | 10.87 | ― | 4.20% | 14.00% | 48.03% | |
78 Outperform | ¥91.04B | 8.38 | ― | 3.82% | 3.17% | 654.02% | |
73 Outperform | ¥209.49B | 23.05 | ― | 2.50% | 2.57% | 9.10% | |
71 Outperform | ¥108.14B | 14.78 | ― | 4.64% | 1.98% | -17.68% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥132.27B | 26.15 | ― | 3.77% | -2.59% | 9.56% |